Literature DB >> 21351112

Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma.

Stefano Ginanni Corradini, Maria Antonella Burza, Antonio Molinaro, Stefano Romeo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21351112     DOI： 10.1002/hep.24244

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  22 in total

1.  Understanding the role of PNPLA3 genetic variants in patients with chronic hepatitis C infection.

Authors:  Alessio Aghemo
Journal:  Dig Dis Sci       Date:  2012-06-27       Impact factor: 3.199

2.  Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C.

Authors:  Winston Dunn; Maura O'Neil; Jie Zhao; Chuang Hong Wu; Benjamin Roberts; Shweta Chakraborty; Craig Sherman; Brandy Weaver; Ryan Taylor; Jody Olson; Mojtaba Olyaee; Richard Gilroy; Timothy Schmitt; Yu-Jui Yvonne Wan; Steven A Weinman
Journal:  Hepatology       Date:  2013-12-23       Impact factor: 17.425

Review 3.  Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.

Authors:  Hiroyasu Sakai; Yohei Shirakami; Masahito Shimizu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Authors:  Pierre Nahon; Angela Sutton; Marianne Ziol; Jessica Zucman-Rossi; Jean-Claude Trinchet; Nathalie Ganne-Carrié
Journal:  Hepat Oncol       Date:  2015-01-12

Review 5.  The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.

Authors:  Amit G Singal; Hema Manjunath; Adam C Yopp; Muhammad S Beg; Jorge A Marrero; Purva Gopal; Akbar K Waljee
Journal:  Am J Gastroenterol       Date:  2014-01-21       Impact factor: 10.864

Review 6.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

7.  Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.

Authors:  Y Liu; C A Fernandez; C Smith; W Yang; C Cheng; J C Panetta; N Kornegay; C Liu; L B Ramsey; S E Karol; L J Janke; E C Larsen; N Winick; W L Carroll; M L Loh; E A Raetz; S P Hunger; M Devidas; J J Yang; C G Mullighan; J Zhang; W E Evans; S Jeha; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2017-04-04       Impact factor: 6.875

Review 8.  Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.

Authors:  Shijie Zhang; Hexing Wu; Xiangwei Wu; Webo Lian; Yanchao Wang; Xiaozhao Zhang; Xinyu Peng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 9.  Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.

Authors:  Bratati Kahali; Brian Halligan; Elizabeth K Speliotes
Journal:  Semin Liver Dis       Date:  2015-12-16       Impact factor: 6.115

10.  PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection.

Authors:  Karolina Rembeck; Cristina Maglio; Martin Lagging; Peer Brehm Christensen; Martti Färkkilä; Nina Langeland; Mads Rauning Buhl; Court Pedersen; Kristine Mørch; Gunnar Norkrans; Kristoffer Hellstrand; Magnus Lindh; Carlo Pirazzi; Maria Antonella Burza; Stefano Romeo; Johan Westin
Journal:  BMC Med Genet       Date:  2012-09-14       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.